secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quince Therapeutics, Inc. (QNCX)
CIK:        0001662774
Form:       8-K
Filed at:   2026-03-20T23:59:59+00:00
Accession:  0001193125-26-117794
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Quince Therapeutics receives two Nasdaq deficiency notices with 180-day cure periods
--------------------------------------------------------------------------------

- Bid Price Notice: common stock closing bid below $1.00 for 30 consecutive business days; cure by Sept 14, 2026.
- MVLS Notice: market value of listed securities below $50M for 30 consecutive business days; cure by Sept 14, 2026.
- To regain compliance, bid price must close at $1+ for 10 consecutive days, or MVLS at $50M+ for 10 consecutive days.
- If not cured by deadline, company may transfer to Nasdaq Capital Market or face delisting.
- Stock continues trading on Nasdaq under symbol QNCX during cure period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662774/000119312526117794/0001193125-26-117794-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662774/000119312526117794/d122428d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-117794

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer